CLINICAL_TRIALS
trial_result
· 2014-06-18
Clinical Trial Update: Saxagliptin and Atherosclerosis [Phase 4]
Summary
Phase 4 clinical trial update indicating the saxagliptin study in patients with coronary artery disease and type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oslo University Hospital | Conditions: Coronary Artery Disease, Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED